Latest filing published 08 Jan 2025 for Acurx Pharmaceuticals, Inc., €9,703.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -81.9%Entry US$16.16 · Close at T+365 US$2.93
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jack H. Dean: trading record in brief
Jack H. Dean discloses dealings in 2 companies, chiefly PLx Pharma Inc. and Acurx Pharmaceuticals, Inc. In total, 3 filings cover trades dated from 18 March 2014 to 6 January 2025.
On the market, this insider has only ever bought: 3 purchases, €47k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2025 alone, the filings show 1 purchase and no sales.
Half of the purchases are above €18k and half below.
The newest entry dates from 8 January 2025: an open-market purchase of €9,703, in Acurx Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jack H. Dean
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,852 shares@ US$1.015100.0% of flowCommon StockSEC:0001104659-25-002046:0Canonical exit: 6 Apr 2025 (T+90)
- 3,000 shares@ US$9.00Common Stock, par value $.001 per shareSEC:0001104659-14-041088:0Canonical exit: 19 Aug 2014 (T+90)
2 of 2 declarations
